Tectonic Therapeutic (TECX) Share-based Compensation (2017 - 2026)

Tectonic Therapeutic (TECX) has reported Share-based Compensation for 10 consecutive years, with $3.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Share-based Compensation rose 77.37% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $11.6 million (up 433.41% YoY), while the FY2025 annual figure was $10.5 million, down 21.08% from the prior year.
• Share-based Compensation improved to $3.7 million in Q1 2026 per TECX's latest filing, from $3.0 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $24.0 million in Q2 2025 and bottomed at -$2.0 million in Q4 2024.
• Historically, Share-based Compensation has averaged $2.7 million across 5 years, with a median of $1.6 million in 2024.
• Annual changes were most pronounced in 2023 — Share-based Compensation soared 252900.0% — and 2024, when it sank 771.43%.
• Tectonic Therapeutic's Share-based Compensation stood at $2000.0 in 2022, then soared by 14600.0% to $294000.0 in 2023, then slumped by 771.43% to -$2.0 million in 2024, then surged by 251.42% to $3.0 million in 2025, then gained by 24.79% to $3.7 million in 2026.
• Business Quant data shows TECX's Share-based Compensation at $3.7 million in Q1 2026, $3.0 million in Q4 2025, and $2.8 million in Q3 2025.